Indication

Relapsing remitting multiple sclerosis

Relapsing-remitting multiple sclerosis is a chronic, immune-mediated neurodegenerative disorder of the central nervous system and represents the most common clinical phenotype of multiple sclerosis. Read more about Relapsing remitting multiple sclerosis

2 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Relapsing remitting multiple sclerosis therapies.

Showing 1–2 of 2 drugs

OCREVUS (ocrelizumab)

MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES·RELAPSING REMITTING MULTIPLE SCLEROSIS·+3
GENENTECH
Filter & compare in the drug finder →Opens the drug finder with Relapsing remitting multiple sclerosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Relapsing remitting multiple sclerosis.

Relapsing-remitting multiple sclerosis is a chronic, immune-mediated neurodegenerative disorder of the central nervous system and represents the most common clinical phenotype of multiple sclerosis.

Primarily affecting young adults, particularly females, it is driven pathologically by autoimmune inflammatory attacks targeting the protective myelin sheath and underlying axons within the brain, optic nerves, and spinal cord.

Clinically, it is defined by discrete episodes of acute or subacute neurologic dysfunction—termed relapses or exacerbations—followed by periods of partial or complete symptom recovery and relative disease stability during remission.

Over time, repeated attacks and incomplete remissions can cause cumulative axonal injury, leading to progressive neurological impairment.

Personalize your experience

Follow Relapsing remitting multiple sclerosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it